Please ensure Javascript is enabled for purposes of website accessibility



We have the knowledge and expertise to handle the most demanding and complex transactions and provide expert, efficient and cost effective services to all our clients. Our commercial understanding and experience of working with leading financial institutions, professional advisers and regulatory bodies enable us to add real value to our clients’ businesses.

View all services


Our experts provide independent guidance spanning advice and training to implementation and evaluation across sustainable investing, regulatory compliance and tech. Our tailored advice meets clients' specific needs, delivering flexible solutions and support.

View all Consulting


Our sector approach relies on smart collaboration between our business divisions, our service lines and our jurisdictions. These sector-based teams have a deep understanding of related businesses and industry dynamics. The specific combination of our highly informed experts helps our clients see around corners.

View all sectors


Ogier provides practical advice on BVI, Cayman Islands, Guernsey, Irish, Jersey and Luxembourg law through our global network of offices across the Asian, Caribbean and European timezones. Ogier is the only firm to advise on this unique combination of laws.

News and insights

Keep up to date with industry insights, analysis and reviews. Find out about the work of our expert teams and subscribe to receive our newsletters straight to your inbox.

Fresh thinking, sharper opinion.

About us

We get straight to the point, managing complexity to get to the essentials. Our global network of offices covers every time zone. 

No Content Set

Ogier advises Virax Biolabs Group Limited on private placement priced at the market


16 March 2023

Hong Kong, Cayman Islands

Save as PDF

Ogier acted as Cayman Islands legal adviser to the Virax Biolabs Group Limited on its private placement of its ordinary shares (or ordinary share equivalents), series A preferred investments options and series B preferred investment priced at the market under Nasdaq rules.

The company previously closed another private placement of its ordinary shares and unregistered warrants in November 2022, in which Ogier also acted as Cayman Islands counsel.

Virax Biolabs is a Nasdaq-listed innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases. The company intends to use the net proceeds from the private placements for the development and commercialisation of its proprietary T-Cell Test technology as well as for working capital and other general corporate purposes.

The Ogier team in Hong Kong was led by corporate partner Florence Chan with support from global head of corporate Nathan Powell, associate Anna Cheung and paralegal Jenson Ng.

No Content Set